| scholarly article | Q13442814 |
| P50 | author | Reiko Nishihara | Q95974375 |
| Shuji Ogino | Q18055035 | ||
| Edward L. Giovannucci | Q20740896 | ||
| Danny Milner | Q40470741 | ||
| Akihiro Nishi | Q57470201 | ||
| P2093 | author name string | Ichiro Kawachi | |
| Andy S Tan | |||
| P2860 | cites work | Establishment of the cancer prevention study II nutrition cohort colorectal tissue repository | Q86181993 |
| The relationship of fetal and infant mortality to residential segregation: an inquiry into social epidemiology. 1949 | Q86501941 | ||
| Lifestyle and family history influence cancer prognosis in Brazilian individuals | Q86619844 | ||
| What is behind the remarkable increase in esophageal adenocarcinoma? | Q87402036 | ||
| Bridging behavior and biology to reduce socioeconomic disparities in colorectal cancer risk | Q95407965 | ||
| Social relationships and mortality risk: a meta-analytic review | Q21144627 | ||
| Mendelian randomisation and causal inference in observational epidemiology | Q21144649 | ||
| Cancer classification using the Immunoscore: a worldwide task force | Q21245495 | ||
| ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?* | Q22066036 | ||
| The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists | Q24289206 | ||
| Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science | Q24289208 | ||
| Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease | Q24289344 | ||
| Integrative cancer epidemiology--the next generation | Q24594622 | ||
| CpG island methylation in colorectal cancer: past, present and future | Q24597977 | ||
| Molecular pathology in epidemiologic studies: a primer on key considerations | Q24598972 | ||
| Genomic analysis identifies association of Fusobacterium with colorectal carcinoma | Q24603176 | ||
| Can tissue-based immune markers be used for studying the natural history of cancer? | Q24605537 | ||
| Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers | Q24611043 | ||
| Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field | Q24620628 | ||
| Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology | Q24622814 | ||
| The science and art of molecular epidemiology | Q24682808 | ||
| Potential of epigenetic therapies in the management of solid tumors | Q26783134 | ||
| Serrated lesions of the colorectum: review and recommendations from an expert panel | Q26827208 | ||
| Developing precision medicine in a global world | Q26850961 | ||
| How many molecular subtypes? Implications of the unique tumor principle in personalized medicine | Q26992045 | ||
| PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer | Q35815544 | ||
| Aspirin use and cardiovascular events in social networks | Q35818810 | ||
| Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status. | Q35855391 | ||
| Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer | Q35881186 | ||
| A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers. | Q35896952 | ||
| Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype | Q35920915 | ||
| Fusobacterium nucleatum and T Cells in Colorectal Carcinoma | Q35956384 | ||
| Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer | Q36051807 | ||
| Epigenetics and colorectal cancer | Q36081553 | ||
| Molecular pathological epidemiology gives clues to paradoxical findings | Q36264731 | ||
| Income inequality and population health: a review and explanation of the evidence | Q36286932 | ||
| Buddy Study: Partners for better health in adolescents with type 2 diabetes | Q36400385 | ||
| MicroRNA MIR21 and T Cells in Colorectal Cancer | Q36436728 | ||
| Detecting and exploiting etiologic heterogeneity in epidemiologic studies | Q36489228 | ||
| Instruments for causal inference: an epidemiologist's dream? | Q36498027 | ||
| Social support and health: a review of physiological processes potentially underlying links to disease outcomes | Q36499059 | ||
| Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation | Q36551145 | ||
| The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach | Q36582330 | ||
| Socioeconomic status, p53 abnormalities, and colorectal cancer | Q36582570 | ||
| Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women | Q36645919 | ||
| Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. | Q36675320 | ||
| A population approach to precision medicine | Q36776351 | ||
| MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. | Q36871986 | ||
| Risk factors for serrated polyps of the colorectum | Q36938837 | ||
| A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification | Q36974863 | ||
| Epigenetics and colorectal cancer pathogenesis | Q37061792 | ||
| Aspirin use and risk of colorectal cancer according to BRAF mutation status | Q37094281 | ||
| Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location | Q37111201 | ||
| Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention | Q37139174 | ||
| CpG island methylator phenotype (CIMP) in cancer: causes and implications | Q37159995 | ||
| Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. | Q37172368 | ||
| CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology. | Q37261842 | ||
| Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study | Q37265129 | ||
| Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas | Q37274510 | ||
| Characterizing the prevalence of chromosome instability in interval colorectal cancer | Q35214558 | ||
| Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women | Q35251758 | ||
| Fusobacterium in colonic flora and molecular features of colorectal carcinoma. | Q35404536 | ||
| Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability | Q35474059 | ||
| Cancer immunology--analysis of host and tumor factors for personalized medicine | Q35583180 | ||
| Mendelian randomization study of height and risk of colorectal cancer | Q35784595 | ||
| DNA methylation biomarkers: cancer and beyond | Q26996421 | ||
| Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids | Q26996516 | ||
| Molecular pathways and cellular metabolism in colorectal cancer | Q27006056 | ||
| Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways | Q27010030 | ||
| Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology | Q27011884 | ||
| Towards the introduction of the 'Immunoscore' in the classification of malignant tumours | Q27026489 | ||
| Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. | Q27851408 | ||
| Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis | Q27851573 | ||
| Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review | Q28081212 | ||
| Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer | Q28084346 | ||
| Developing genomic knowledge bases and databases to support clinical management: current perspectives | Q28249073 | ||
| Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival | Q28277824 | ||
| Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features | Q28284149 | ||
| Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer | Q28299100 | ||
| Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! | Q28301003 | ||
| Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer | Q28305293 | ||
| A new initiative on precision medicine | Q29615654 | ||
| Marginal structural models and causal inference in epidemiology | Q29619287 | ||
| Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study | Q30543607 | ||
| Alcohol and breast cancer: reconciling epidemiological and molecular data | Q30872137 | ||
| CIMP status of interval colon cancers: another piece to the puzzle | Q33348336 | ||
| Distinct high-profile methylated genes in colorectal cancer | Q33502762 | ||
| Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases | Q33625221 | ||
| Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry | Q33636690 | ||
| Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer | Q33643298 | ||
| Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD) | Q33648694 | ||
| Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention | Q33661094 | ||
| Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability | Q33696650 | ||
| p53 mutation, deprivation and poor prognosis in primary breast cancer | Q33723628 | ||
| Associations between estrogen receptor-negative breast cancer and timing of reproductive events differ between African American and European American women | Q33759719 | ||
| Aspirin use and survival after diagnosis of colorectal cancer | Q33764480 | ||
| Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). | Q33869180 | ||
| A conceptual and methodological framework for investigating etiologic heterogeneity | Q33923726 | ||
| DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia | Q34000385 | ||
| Body mass index, diabetes, and mortality in French women: explaining away a "paradox". | Q34004440 | ||
| Vitamin D, Inflammation, and Colorectal Cancer Progression: A Review of Mechanistic Studies and Future Directions for Epidemiological Studies | Q38591338 | ||
| Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis | Q40603067 | ||
| Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway | Q41372623 | ||
| Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences | Q41779251 | ||
| Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy? | Q42097290 | ||
| Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry | Q42510173 | ||
| The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. | Q42642063 | ||
| Potential role of gastrointestinal microbiota composition in prostate cancer risk. | Q42908744 | ||
| Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. | Q43274574 | ||
| Body size, physical activity, early-life energy restriction, and associations with methylated insulin-like growth factor-binding protein genes in colorectal cancer | Q44043770 | ||
| Association of education and income with estrogen receptor status in primary breast cancer | Q45124549 | ||
| Socioeconomic status in health research: one size does not fit all. | Q46438083 | ||
| Quality pathology and laboratory diagnostic services are key to improving global health outcomes: improving global health outcomes is not possible without accurate disease diagnosis | Q46530756 | ||
| The merits of subtyping obesity: one size does not fit all. | Q47201724 | ||
| A prospective study of serum metabolites and colorectal cancer risk | Q48858624 | ||
| Aetiological stratification as a conceptual framework for gene-by-environment interaction research in psychiatry. | Q50596761 | ||
| Public Health in the Precision-Medicine Era. | Q50880257 | ||
| Associations among social capital, parenting for active lifestyles, and youth physical activity in rural families living in upstate New York. | Q51341784 | ||
| An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. | Q51825005 | ||
| Causation and causal inference in epidemiology. | Q52043839 | ||
| Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. | Q54568648 | ||
| Body mass index and microsatellite instability in colorectal cancer: a population-based study. | Q54758564 | ||
| Molecular backgrounds of ERAP1 downregulation in cervical carcinoma. | Q55437991 | ||
| New Insights on Bariatric Surgery Outcomes | Q56095647 | ||
| Partners in Pathology: A Collaborative Model to Bring Pathology to Resource Poor Settings | Q57062525 | ||
| Reduced Risk of Colorectal Cancer Up to 10 Years After Screening, Surveillance, or Diagnostic Colonoscopy | Q57191776 | ||
| Risk of Microsatellite-Unstable Colorectal Cancer Is Associated Jointly with Smoking and Nonsteroidal Anti-inflammatory Drug Use | Q57268385 | ||
| Social deprivation and breast cancer | Q57556138 | ||
| From counterfactuals to sufficient component causes and vice versa | Q79566671 | ||
| Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma | Q83081238 | ||
| Research agenda. Promoting convergence in biomedical science | Q84614942 | ||
| Cigarette smoking and colorectal cancer risk by molecularly defined subtypes | Q34042268 | ||
| Theories for social epidemiology in the 21st century: an ecosocial perspective | Q34087328 | ||
| Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry | Q34155082 | ||
| CpG island methylator phenotype and prognosis of colorectal cancer in Northeast China. | Q34177058 | ||
| The CpG island methylator phenotype in colorectal cancer: progress and problems | Q34230273 | ||
| Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. | Q34269998 | ||
| Cholesterol metabolism and colorectal cancers. | Q34293436 | ||
| Commentary: Resolutions of the birthweight paradox: competing explanations and analytical insights | Q34309807 | ||
| Conventional and nanotechniques for DNA methylation profiling | Q34310031 | ||
| Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker | Q34333522 | ||
| Analysis of cohort studies with multivariate and partially observed disease classification data | Q34347752 | ||
| The CpG island methylator phenotype: what's in a name? | Q34353612 | ||
| Diagnostic biomarkers are hidden in the infected host's epigenome | Q34360404 | ||
| The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium | Q34376200 | ||
| Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations | Q34390505 | ||
| Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. | Q34441501 | ||
| Nutrients, foods, and colorectal cancer prevention | Q34457478 | ||
| The precision medicine initiative: a new national effort | Q34474452 | ||
| Proceedings of the second international molecular pathological epidemiology (MPE) meeting | Q34475686 | ||
| Inequality and visibility of wealth in experimental social networks | Q34493330 | ||
| A strategy for distinguishing optimal cancer subtypes | Q34594334 | ||
| Income inequality, mortality, and self rated health: meta-analysis of multilevel studies | Q34613709 | ||
| The increasing dominance of teams in production of knowledge | Q34618686 | ||
| Mendelian randomization: how it can--and cannot--help confirm causal relations between nutrition and cancer | Q34642802 | ||
| Diet and lifestyle in survivors of colorectal cancer | Q34650201 | ||
| Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium | Q34736954 | ||
| Lifecourse epidemiology and molecular pathological epidemiology. | Q34762152 | ||
| Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer | Q34921255 | ||
| Genomic investigation of etiologic heterogeneity: methodologic challenges | Q34937805 | ||
| Estrogen receptors and their implications in colorectal carcinogenesis | Q35037282 | ||
| Mechanisms of obesity-induced gastrointestinal neoplasia | Q35062195 | ||
| Translational cancer research: balancing prevention and treatment to combat cancer globally | Q35102711 | ||
| Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer | Q35138892 | ||
| Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history | Q35163670 | ||
| Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers | Q37276215 | ||
| Long-term colorectal-cancer incidence and mortality after lower endoscopy | Q37341827 | ||
| Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status | Q37382206 | ||
| Racial disparities in red meat and poultry intake and breast cancer risk | Q37415169 | ||
| Somatic alterations, metabolizing genes and smoking in rectal cancer | Q37435772 | ||
| Social epidemiology: social determinants of health in the United States: are we losing ground? | Q37586394 | ||
| Biomarkers in precision therapy in colorectal cancer. | Q37609130 | ||
| PIK3CA in Colorectal Cancer | Q37612390 | ||
| Aspirin and colorectal cancer: back to the future | Q37626475 | ||
| Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. | Q37632196 | ||
| Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry | Q37649665 | ||
| Methodological challenges in mendelian randomization | Q37694967 | ||
| Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates | Q37706552 | ||
| Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer. | Q37708015 | ||
| Oncogenic mutations as predictive factors in colorectal cancer | Q37728856 | ||
| Breast cancer racial disparities: unanswered questions | Q37816759 | ||
| Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms | Q38036541 | ||
| The obesity paradox: understanding the effect of obesity on mortality among individuals with cardiovascular disease | Q38187787 | ||
| The role of epigenetics in colorectal cancer | Q38215665 | ||
| Racial/ethnic disparities in human DNA methylation | Q38228654 | ||
| Biological significance of the CpG island methylator phenotype | Q38228662 | ||
| Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis | Q38232753 | ||
| Epigenetic epidemiology of cancer | Q38240033 | ||
| Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis | Q38252696 | ||
| Colorectal serrated pathway cancers and precursors | Q38255029 | ||
| Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays | Q38299809 | ||
| Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study | Q38401874 | ||
| Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis | Q38403904 | ||
| The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status | Q38417609 | ||
| Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients | Q38445688 | ||
| Addressing the needs of colorectal cancer survivors: current strategies and future directions | Q38451230 | ||
| Serrated neoplasia-role in colorectal carcinogenesis and clinical implications | Q38473801 | ||
| Adiposity and cancer risk: new mechanistic insights from epidemiology | Q38553013 | ||
| P433 | issue | 1 | |
| P921 | main subject | social science | Q34749 |
| epidemiology | Q133805 | ||
| P304 | page(s) | 11-23 | |
| P577 | publication date | 2015-12-04 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | Integration of molecular pathology, epidemiology and social science for global precision medicine | |
| P478 | volume | 16 |
| Q92145561 | A meta-analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases |
| Q93013367 | A meta-analysis on associations of FTO, MTHFR and TCF7L2 polymorphisms with polycystic ovary syndrome |
| Q91744544 | A meta-analysis on genetic associations between Transcription Factor 7 Like 2 polymorphisms and type 2 diabetes mellitus |
| Q91996155 | Associations between genetic polymorphisms of TLRs and susceptibility to tuberculosis: A meta-analysis |
| Q91925279 | Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis |
| Q91165738 | Associations of genetic polymorphisms in CTLA-4 and IL-18 with chronic liver diseases: Evidence from a meta-analysis |
| Q64905433 | Associations of leptin and leptin receptor genetic variants with coronary artery disease: a meta-analysis. |
| Q52624157 | Big Data's Role in Precision Public Health. |
| Q90364764 | CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies |
| Q38753775 | Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives |
| Q39037684 | Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases |
| Q57105691 | Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation? |
| Q91939484 | Genetic associations between Transcription Factor 7 Like 2 rs7903146 polymorphism and type 2 diabetes mellitus: a meta-analysis of 115,809 subjects |
| Q42680523 | How will the 'cancer moonshot' impact health disparities? |
| Q62494554 | Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology |
| Q53601791 | Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. |
| Q50043586 | Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine |
| Q64886283 | Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses. |
| Q30244608 | Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. |
| Q42697467 | On the road to personalised and precision geomedicine: medical geology and a renewed call for interdisciplinarity |
| Q30238962 | Proceedings of the third international molecular pathological epidemiology (MPE) meeting |
| Q41512259 | Prominent features of the amino acid mutation landscape in cancer. |
| Q53755173 | Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine. |
| Q89515595 | Relationship between common eNOS gene polymorphisms and predisposition to coronary artery disease: Evidence from a meta-analysis of 155 published association studies |
| Q91696002 | Relationship of genetic polymorphisms in CTLA-4 and IL-18 with viral hepatitis: evidence from a meta-analysis |
| Q30239977 | Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach? |
| Q57254075 | Strategies for integrating personalized medicine into healthcare practice |
| Q91915994 | The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects |
| Q28072100 | Transdisciplinary approaches enhance the production of translational knowledge |
| Q31137610 | Transforming big data into computational models for personalized medicine and health care |
| Q47271626 | Utility of inverse probability weighting in molecular pathological epidemiology |
Search more.